Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0UM4R
|
|||
Former ID |
DNC012199
|
|||
Drug Name |
(2-Chloro-9-methyl-9H-purin-6-yl)-phenyl-amine
|
|||
Synonyms |
CHEMBL98779; (2-Chloro-9-methyl-9H-purin-6-yl)-phenyl-amine; 2-chloro-9-methyl-N6-phenyladenine; 135394-17-1; SCHEMBL183230; DBTWDYPKBBODMU-UHFFFAOYSA-N; BDBM50009679; 2-Chloro-9-methyl-N-phenyl-9H-purin-6-amine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H10ClN5
|
|||
Canonical SMILES |
CN1C=NC2=C(N=C(N=C21)Cl)NC3=CC=CC=C3
|
|||
InChI |
1S/C12H10ClN5/c1-18-7-14-9-10(16-12(13)17-11(9)18)15-8-5-3-2-4-6-8/h2-7H,1H3,(H,15,16,17)
|
|||
InChIKey |
DBTWDYPKBBODMU-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 135394-17-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adenosine A1 receptor (ADORA1) | Target Info | Inhibitor | [1] |
KEGG Pathway | cGMP-PKG signaling pathway | |||
cAMP signaling pathway | ||||
Sphingolipid signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
Morphine addiction | ||||
NetPath Pathway | TCR Signaling Pathway | |||
RANKL Signaling Pathway | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
Reactome | Adenosine P1 receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Nucleotide GPCRs | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor. J Med Chem. 1991 Sep;34(9):2877-82. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.